Covert Dyskinesia Associated With Aripiprazole: A Case Report and Review of the Literature

The atypical antipsychotic agents are felt by many to have a lower risk of inducing the development of dyskinetic movements than the conventional antipsychotic agents agents such as haloperidol and fluphenazine. However, that does not mean that treatment with the atypical antipsychotic agents carrie...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Clinical neuropharmacology 2013-07, Vol.36 (4), p.128-130
Hauptverfasser:	MOSELEY, Carrie N, SIMPSON-KHANNA, Heather A, CATALANO, Glenn, CATALANO, Maria C
Format:	Artikel
Sprache:	eng
Schlagworte:	Aged Akathisia, Drug-Induced - diagnosis Akathisia, Drug-Induced - etiology Antipsychotic Agents - adverse effects Antipsychotic Agents - therapeutic use Aripiprazole Biological and medical sciences Depressive Disorder, Major - drug therapy Diagnosis, Differential Dopamine Agents - adverse effects Dopamine Agents - therapeutic use Drug Monitoring Drug Therapy, Combination - adverse effects Dyskinesia, Drug-Induced - diagnosis Dyskinesia, Drug-Induced - etiology Dyskinesia, Drug-Induced - physiopathology Dyskinesia, Drug-Induced - prevention & control Humans Male Mandible Medical sciences Mouth Movement Disorders - diagnosis Movement Disorders - etiology Nervous system (semeiology, syndromes) Nervous system as a whole Neurology Neuropharmacology Pharmacology. Drug treatments Piperazines - adverse effects Piperazines - therapeutic use Psycholeptics: tranquillizer, neuroleptic Psychology. Psychoanalysis. Psychiatry Psychopharmacology Quinolones - adverse effects Quinolones - therapeutic use Severity of Illness Index Substance Withdrawal Syndrome - diagnosis Substance Withdrawal Syndrome - physiopathology Tetrabenazine - therapeutic use Treatment Outcome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!